March 20, 2017 / 7:28 AM / 4 months ago

BRIEF-Salvarx Group says unit to invest in Rift Biotherapeutics

1 Min Read

March 20 (Reuters) - Salvarx Group Plc

* Says unit Salvarx Ltd, entered into agreement to invest in rift biotherapeutics, a biotechnology co in development of antibodies for use in oncology

* Says salvarx will invest $1,000,000 for an initial holding of about 30 percent Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below